Testing Choices: From the standard to the extraordinary
Test | Test Name |
---|---|
1919FL | Electrolytes and Glucose Panel (Vitreous), Fluid (Forensic) |
1923B | Enflurane, Blood |
1968B | Eszopiclone / Zopiclone, Blood |
1968SP | Eszopiclone / Zopiclone, Serum/Plasma |
1968TI | Eszopiclone / Zopiclone, Tissue |
1968U | Eszopiclone / Zopiclone, Urine |
1970SP | Ethchlorvynol, Serum/Plasma |
1970U | Ethchlorvynol Overdose, Urine |
1980B | Ethinamate, Blood |
1980SP | Ethinamate, Serum/Plasma |
2000B | Ethosuximide, Blood |
2000SP | Ethosuximide, Serum/Plasma |
2000U | Ethosuximide, Urine |
2010B | Ethotoin, Blood |
2010SP | Ethotoin, Serum/Plasma |
2063B | Etomidate, Blood |
2063P | Etomidate, Plasma |
2066B | Everolimus, Blood |
4025SP | Ezogabine and Metabolite, Serum/Plasma |
9171B | Ethosuximide Screen, Blood |
9171SP | Ethosuximide Screen, Serum/Plasma |
9171U | Ethosuximide Screen, Urine |
9352UC | Expanded Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |